These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 5432229)
1. Catechol-O-methyltransferase. II. A new class of inhibitors of catechol-o-methyltransferase; 3,5-dihydroxy-4-methoxybenzoic acid and related compounds. Nikodejevic B; Senoh S; Daly JW; Creveling CR J Pharmacol Exp Ther; 1970 Jul; 174(1):83-93. PubMed ID: 5432229 [No Abstract] [Full Text] [Related]
2. Catechol O-methyltransferase. The para- and meta-O-methylations of noradrenaline. Frère JM; Verly WG Biochim Biophys Acta; 1971 Apr; 235(1):73-84. PubMed ID: 5519141 [No Abstract] [Full Text] [Related]
3. Catechol O-methyltransferase. IV. Factors affecting m- and p-methylation of substituted catechols. Creveling CR; Morris N; Shimizu H; Ong HH; Daly J Mol Pharmacol; 1972 Jul; 8(4):398-409. PubMed ID: 4340872 [No Abstract] [Full Text] [Related]
4. Pyridoxal-5'-phosphate--an inhibitor of catechol-O-methyltransferase in vitro. Black IB Biochem Pharmacol; 1971 Apr; 20(4):924-7. PubMed ID: 5571025 [No Abstract] [Full Text] [Related]
10. A comparison of brain and liver catechol O-methyltransferase. Rock GD; Tong JH; D'Iorio AD Can J Biochem; 1970 Dec; 48(12):1326-31. PubMed ID: 4995113 [No Abstract] [Full Text] [Related]
11. Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver. Ball P; Knuppen R; Haupt M; Breuer H J Clin Endocrinol Metab; 1972 Apr; 34(4):736-46. PubMed ID: 5012775 [No Abstract] [Full Text] [Related]
12. The catechol-O-methyl transferase activity and endogenous catecholamine content of various tissues in the rat and the effect of administration of U-0521 (3',4'-dihydroxy-2-methyl propiophenone). Giles RE; Miller JW J Pharmacol Exp Ther; 1967 Nov; 158(2):189-94. PubMed ID: 5625691 [No Abstract] [Full Text] [Related]
13. Synthesis and evaluation of bifunctional nitrocatechol inhibitors of pig liver catechol-O-methyltransferase. Bailey K; Tan EW Bioorg Med Chem; 2005 Oct; 13(20):5740-9. PubMed ID: 16002297 [TBL] [Abstract][Full Text] [Related]
15. Insoluble solid complexes of norepinephrine and adenosine triphosphate. Maynert EW; Moon BH; Pai VS Mol Pharmacol; 1972 Jan; 8(1):88-94. PubMed ID: 5061520 [No Abstract] [Full Text] [Related]
16. Kinetic studies on catechol O-methyltransferase. Product inhibition and the nature of the catechol binding site. Coward JK; Slixz EP; Wu FY Biochemistry; 1973 Jun; 12(12):2291-7. PubMed ID: 4736330 [No Abstract] [Full Text] [Related]
17. Enzymic methylation of L-ascorbic acid by catechol O-methyltransferase. Blaschke E; Hertting G Biochem Pharmacol; 1971 Jul; 20(7):1363-70. PubMed ID: 5163077 [No Abstract] [Full Text] [Related]
18. Inhibition of human liver catechol-O-methyltransferase by flavonoids. Gugler R; Dengler HJ Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(2):223-33. PubMed ID: 4268471 [No Abstract] [Full Text] [Related]
19. Catechol-O-methyl transferase and monoamine oxidase activities in the heart and liver of the embryonic and developing chick. Ignarro LJ; Shideman FE J Pharmacol Exp Ther; 1968 Jan; 159(1):29-37. PubMed ID: 5643948 [No Abstract] [Full Text] [Related]
20. Inhibitory effects of 3, 5-diiodo-4-hydroxybenzoic acid on the catechol-O-methyltransferase activity in a crude enzyme preparation. D'IORIO A; MAVRIDES C Can J Biochem Physiol; 1962 Oct; 40():1454-6. PubMed ID: 13883019 [No Abstract] [Full Text] [Related] [Next] [New Search]